You are here

  • Home
  • Archive
  • Volume 67, Issue 4
  • National audit of supported discharge programmes for management of acute exacerbations of chronic obstructive pulmonary disease 2008

Article Text

Article menu

Download PDFPDF

Chest clinic
Audit update
National audit of supported discharge programmes for management of acute exacerbations of chronic obstructive pulmonary disease 2008
Free
  1. Jack A Kastelik1,
  2. Derek Lowe2,
  3. Robert A Stone2,3,
  4. Rhona J Buckingham2,
  5. C Michael Roberts2,4
  1. 1Department of Respiratory Medicine, Castle Hill Hospital, Hull and East Yorkshire NHS Trust, University of Hull and Hull York Medical School, Cottingham, East Yorkshire, UK
  2. 2Clinical Standards Department, Royal College of Physicians, London, UK
  3. 3Taunton and Somerset NHS Trust, Musgrove Park Hospital, Taunton, UK
  4. 4Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK
  1. Correspondence to Dr Jack Kastelik, Department of Respiratory Medicine, Castle Hill Hospital, University of Hull and Hull York Medical School, Cottingham, East Yorkshire HU16 5JQ, UK; jack.kastelik{at}hull.ac.uk

Abstract

The 2008 UK national chronic obstructive pulmonary disease (COPD) audit examined the use of supported discharge programmes (SDPs) in clinical practice against British Thoracic Society guidelines. 98% of acute UK trusts participated. SDPs were available in 142 of 239 (59%) units. 1630 of 8971 (18%) patients with COPD were treated within SDPs. Median (IQR) stay in hospital for patients within SDPs and those not accepted for SDPs was 3 (1–6) days and 6 (3–11) days (p<0.001), and mortality within 90 days of admission was 4.3% and 6.7%, respectively. SDPs within the UK are safe and effective and reduce length of hospital stay without adverse effects on mortality.

  • COPD exacerbations
  • COPD pharmacology
  • emphysema
  • COPD epidemiology

https://doi.org/10.1136/thoraxjnl-2011-200884

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Funding This study was supported by the British Lung Foundation, British Thoracic Society, Royal College of Physicians and guided by the National COPD Resources and Outcomes Project (NCROP) steering group. It was funded by the Health Foundation.

    • Competing interests None.

    • Ethics approval Ethics approval was provided by University College Hospital/University College London Multicentre Research Ethics Committee (MREC).

    • Provenance and peer review Not commissioned; externally peer reviewed.